Whereas a reduction of EGFR protein level can lead to cell death in cancer cells, inhibition of tyrosine kinase activity via TKI treatment does not, suggesting the presence of tyrosine kinase-independent actions of EGFR (Katreddy et al., 2018). This evidence concerns the gene EGFR and cancer.